✦ LIBER ✦

Current status and controversial issues concerning endocrine therapy for patients with recurrent breast cancer in Japan

✍ Scribed by Hiroshi Sonoo; Junichi Kurebayashi; Yuichi Lino; Hideo Inaji; Toru Watanabe; Masakazu Toi; Shunzo Kobayashi; Bunzo Sato; Masataka Yoshimoto

Publisher: Springer Japan
Year: 1999
Tongue: English
Weight: 641 KB
Volume: 6
Category: Article
ISSN: 1340-6868
DOI: 10.1007/bf02966451

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive factors for response to endoc

Predictive factors for response to endocrine therapy in patients with recurrent Breast Cancer

✍ Hiroshi Sonoo; Junichi Kurebayashi 📂 Article 📅 2000 🏛 Springer Japan 🌐 English ⚖ 516 KB

Quality of life of Breast Cancer patient

Quality of life of Breast Cancer patients and types of surgery for Breast Cancer — current status and unresolved issues —

✍ Shozo Ohsumi; Kojiro Shimozuma; Katsumasa Kuroi; Michikazu Ono; Hirohisa Imai 📂 Article 📅 2007 🏛 Springer Japan 🌐 English ⚖ 29 KB

Immunohistochemical assessment for estro

Immunohistochemical assessment for estrogen receptor and progesterone receptor status in breast cancer: Analysis for a cut-off point as the predictor for endocrine therapy

✍ Yoshinari Ogawa; Takuya Moriya; Yasuyuki Kato; Mitsue Oguma; Katsumi Ikeda; Tsut 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 972 KB

The impact of tumor progesterone recepto

The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer : A decision analysis

✍ Rinaa S. Punglia; Karen M. Kuntz; Eric P. Winer; Jane C. Weeks; Harold J. Burste 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB 👁 1 views

Optimizing the use of aromatase inhibito

Optimizing the use of aromatase inhibitors in adjuvant therapy for postmenopausal patients with hormone-responsive early breast cancer: current and future prospects

✍ Walter Jonat; Felix Hilpert 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 412 KB

Mediator of DNA damage checkpoint protei

Mediator of DNA damage checkpoint protein 1 (MDC1) expression as a prognostic marker for nodal recurrence in early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy

✍ Akshar N. Patel; Sharad Goyal; Hao Wu; Devora Schiff; Meena S. Moran; Bruce G. H 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 409 KB